A carregar...

Vaccine adjuvants as potential cancer immunotherapeutics

Accumulated evidence obtained from various clinical trials and animal studies suggested that cancer vaccines need better adjuvants than those that are currently licensed, which include the most commonly used alum and incomplete Freund’s adjuvant, because of either a lack of potent anti-tumor immunit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Immunol
Main Authors: Temizoz, Burcu, Kuroda, Etsushi, Ishii, Ken J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4922024/
https://ncbi.nlm.nih.gov/pubmed/27006304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxw015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!